Hemodialysis News

CryoLife Completes Acquisition of Hemosphere - Sacramento Bee



Proactive Investors USA & Canada
 
CryoLife Completes Acquisition of Hemosphere 
Sacramento Bee
Steven G. Anderson, president and chief executive officer of CryoLife, said, "The talented team at Hemosphere has developed a unique technology for end-stage renal disease hemodialysis patients that are otherwise faced with sub-optimal treatment ...
Eden Prairie-Based Med-Device Co. Bought for $17 Million Twin Cities Business Magazine (blog)

all 21 news articles » 


Liberty Dialysis Celebrates Milestone 1000th Patient in Peritoneal Dialysis ... - Sacramento Bee



Liberty Dialysis Celebrates Milestone 1000th Patient in Peritoneal Dialysis ... 
Sacramento Bee
Like hemodialysis, PD is a way to remove waste products from the blood when the kidneys can no longer perform this function. During PD, a catheter attached to the patient's abdominal lining (peritoneum) delivers fluid (dialysate) to the blood vessels.

and more » 


CryoLife to Acquire Hemosphere - MarketWatch (press release)



Proactive Investors USA & Canada
 
CryoLife to Acquire Hemosphere 
MarketWatch (press release)
The HeRO Graft is a proprietary graft-based solution for end-stage renal disease (ESRD) hemodialysis patients with limited access options and central venous obstruction. Under terms of the agreement, CryoLife will acquire Hemosphere for $17.0 million ...
CryoLife To Buy Hemosphere - Quick Facts NASDAQ
CryoLife's CEO Discusses Acquisition of Hemosphere, Inc. Conference (Transcript) Seeking Alpha

all 28 news articles » 


Study Shows NxStage Daily Home Hemodialysis Patients More Likely to Receive ... - MarketWatch (press release)



Study Shows NxStage Daily Home Hemodialysis Patients More Likely to Receive ... 
MarketWatch (press release)
Study First of its Kind to Show Difference in Transplant Incidence Associated with Daily Home Hemodialysis vs. Conventional Thrice-Weekly Dialysis LAWRENCE, Mass., May 11, 2012 /PRNewswire via COMTEX/ -- NxStage® Medical, Inc. (NASDAQ:NXTM) , a leading ...

and more » 


Study Shows NxStage Daily Home Hemodialysis Patients More Likely to Receive ... - Sacramento Bee



Study Shows NxStage Daily Home Hemodialysis Patients More Likely to Receive ... 
Sacramento Bee
Study First of its Kind to Show Difference in Transplant Incidence Associated with Daily Home Hemodialysis vs. Conventional Thrice-Weekly Dialysis By NxStage Medical, Inc. LAWRENCE, Mass., May 11, 2012 -- /PRNewswire/ -- NxStage® Medical, ...

and more » 


Nephros Reports First Quarter 2012 Financial Results - Sacramento Bee



Nephros Reports First Quarter 2012 Financial Results 
Sacramento Bee
In April 2012, Nephros received FDA 510(k) clearance to market the Company's hemodiafiltration (HDF) system for the treatment of patients with chronic renal failure when used with a UF controlled hemodialysis machine that provides ultrapure dialysate ...

and more » 


Exsanguination of a home hemodialysis patient as a result of misconnected ... - 7thSpace Interactive (press release)



Exsanguination of a home hemodialysis patient as a result of misconnected ... 
7thSpace Interactive (press release)
Home hemodialysis is common in New Zealand and associated with lower cost, improvedsurvival and better patient experience. We present the case of a fully trained homehemodialysis patient who exsanguinated at home as a result of an incorrect wash ...

 


Liberty Dialysis Celebrates Milestone 1000th Patient in Peritoneal Dialysis ... - MarketWatch (press release)



Liberty Dialysis Celebrates Milestone 1000th Patient in Peritoneal Dialysis ... 
MarketWatch (press release)
Like hemodialysis, PD is a way to remove waste products from the blood when the kidneys can no longer perform this function. During PD, a catheter attached to the patient's abdominal lining (peritoneum) delivers fluid (dialysate) to the blood vessels.
Various types of dialysis available for those with failing kidneys PennLive.com

all 4 news articles » 


Nephros Reports First Quarter 2012 Financial Results - MarketWatch (press release)



Nephros Reports First Quarter 2012 Financial Results 
MarketWatch (press release)
In April 2012, Nephros received FDA 510(k) clearance to market the Company's hemodiafiltration (HDF) system for the treatment of patients with chronic renal failure when used with a UF controlled hemodialysis machine that provides ultrapure dialysate ...

and more » 


Fish Oil Doesn't Cut Failure Rate of Hemodialysis Grafts - U.S. News & World Report



MD News (press release)
 
Fish Oil Doesn't Cut Failure Rate of Hemodialysis Grafts 
U.S. News & World Report
TUESDAY, May 1 (HealthDay News) -- Taking fish-oil supplements does not significantly lower the failure rate of grafts used for hemodialysis, a new study finds. The study included about 200 North American kidney-failure patients with a synthetic tube ...
Use of Fish Oil Supplements Shows Mixed Results Regarding Graft Patency for ... Newswise (press release)
Fish oil may improve outcomes for kidney patients undergoing hemodialysis News-Medical.net
In CKD, Fish Oil Doesn't Up Hemodialysis Graft Patency MD News (press release)
ThirdAge  -Medscape  -Renal Business Today 
all 25 news articles »